COMMUNIQUÉS West-GlobeNewswire

Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure
17/08/2026
- Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular data center [...]
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
17/08/2026
Restructuring eliminates prior mandatory proceeds sweep and improves capital structure flexibility BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a [...]
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
17/08/2026
Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day TORONTO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN [...]
Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
17/08/2026
ALPHARETTA, Ga., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing first-in-class, new non-opioid medicines to treat pain and [...]
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
17/08/2026
Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearance NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Intelligent [...]
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
17/08/2026
Best Quarter of Flagship Multi-Cancer Early Detection Testing; OneTest™ Revenue Increased 47% Year-Over-Year to $0.7 Million; Gross Profit Increased 87% to $0.3 Million, with Gross Margin Expanding to 41.7% from 30.5% [...]
Pharmacy Planet surpasses 200,000 YouTube subscribers and highlights the growth of its healthcare education platform
17/08/2026
How one UK pharmacy is redefining health education by turning expert conversations into content that hundreds of thousands of people actively choose to watch LONDON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- In an age where [...]
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results
17/08/2026
DENVER, Aug. 17, 2026 (GLOBE NEWSWIRE) -- There is a tendency to think of a Nasdaq listing as simply a better place for a stock to trade. For NeOnc Technologies Holdings (NASDAQ: NTHI), however, the Nasdaq Global Market [...]
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
17/08/2026
The Patent Claims are for the Intended Commercial Formulation of ART27.13 Expected to Extend Patent Protection for ART27.13 through 2041 SOLANA BEACH, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( [...]
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
17/08/2026
Pluri's majority-owned food-tech company adds aquatic cell biology, animal-component-free media capabilities and a European scientific presence Ever After Foods secures an additional $2 million strategic investment [...]
GHK-Cu Peptide Launched By Kylo Peptides for Laboratory Research Applications
17/08/2026
Sheridan,Wyoming, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com ] has added GHK-Cu peptide to its catalog of laboratory research materials, expanding the range of copper-binding compounds [...]
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
17/08/2026
Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; [...]
AB Science annonce le succès du règlement-livraison des titres émis dans le cadre de son placement privé de 14,2 millions d’euros annoncé le 10 aout 2026
17/08/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES DU REGLEMENT-LIVRAISON DES TITRES EMIS DANS LE CADRE DE SON PLACEMENT PRIVE DE 14,2 MILLIONS D’EUROS ANNONCE LE 10 AOUT 2026 Paris, 17 août 2026, 7h30 AB Science S.A. ( [...]
AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026
17/08/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL SETTLEMENT AND DELIVERY OF SECURITIES ISSUED AS PART OF ITS €14.2 MILLION PRIVATE PLACEMENT ANNOUNCED ON AUGUST 10, 2026 Paris, August 17, 2026, 7.30am CET AB Science S. [...]
Zelluna ASA: Notice of EGM – experienced international biotech executive proposed for election to the Board and Board member steps down
17/08/2026
Oslo, 17 August 2026: The Board of Directors of Zelluna ASA (the “Company”) hereby calls for an Extraordinary General Meeting to be held on 9 September 2026 at 13:00 CEST, regarding election of a new member of the [...]
Breast Augmentation in Dubai - Why Surgical Planning Matters More Than the Implant
17/08/2026
DUBAI, United Arab Emirates, Aug. 17, 2026 (GLOBE NEWSWIRE) -- With demand for aesthetic treatments continuing to rise across the UAE, women are increasingly seeking procedures of breast augmentation in Dubai that [...]
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®
17/08/2026
— First global Phase III trial to show significant progression-free and overall survival benefits in this setting — — SAFFRON trial results reinforce TAGRISSO ® as the backbone therapy across EGFRm lung cancer — HONG [...]
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
17/08/2026
NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in [...]
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
14/08/2026
MIRAMAR, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion [...]

Pages